Literature DB >> 29454141

A cluster randomized pilot trial of a tailored worksite smoking cessation intervention targeting Hispanic/Latino construction workers: Intervention development and research design.

Taghrid Asfar1, Alberto J Caban-Martinez2, Laura A McClure3, Estefania C Ruano-Herreria4, Danielle Sierra4, G Gilford Clark4, Daniel Samano4, Noella A Dietz5, Kenneth D Ward6, Kristopher L Arheart4, David J Lee2.   

Abstract

Construction workers have the highest smoking rate among all occupations (39%). Hispanic/Latino workers constitute a large and increasing group in the US construction industry (over 2.6 million; 23% of all workers). These minority workers have lower cessation rates compared to other groups due to their limited access to cessation services, and lack of smoking cessation interventions adapted to their culture and work/life circumstances. Formative research was conducted to create an intervention targeting Hispanic/Latino construction workers. This paper describes the intervention development and the design, methods, and data analysis plans for an ongoing cluster pilot two-arm randomized controlled trial comparing an Enhanced Care worksite cessation program to Standard Care. Fourteen construction sites will be randomized to either Enhanced Care or Standard Care and 126 participants (63/arm) will be recruited. In both arms, recruitment and intervention delivery occur around "food trucks" that regularly visit the construction sites. Participants at Enhanced Care sites will receive the developed intervention consisting of a single face-to-face group counseling session, 2 phone calls, and a fax referral to Florida tobacco quitline (QL). Participants at Standard Care sites will receive a fax referral to the QL. Both groups will receive eight weeks of nicotine replacement treatment and two follow-up assessments at three and six months. Feasibility outcomes are estimated recruitment yield, barriers to delivering the intervention onsite, and rates of adherence/compliance to the intervention, follow-ups, and QL enrollment. Efficacy outcomes are point-prevalence and prolonged abstinence rates at six month follow-up confirmed by saliva cotinine <15 ng/ml.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cluster randomized clinical trial; Feasibly; Formative research; Smoking cessation intervention; Tailored; Worksite

Mesh:

Substances:

Year:  2018        PMID: 29454141      PMCID: PMC6377564          DOI: 10.1016/j.cct.2018.02.007

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  42 in total

1.  Validation of self reported smoking.

Authors:  M Rebagliato
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

Review 2.  Do smoking reduction interventions promote cessation in smokers not ready to quit?

Authors:  Taghrid Asfar; Jon O Ebbert; Robert C Klesges; George E Relyea
Journal:  Addict Behav       Date:  2011-02-12       Impact factor: 3.913

3.  Tools for health: the efficacy of a tailored intervention targeted for construction laborers.

Authors:  Glorian Sorensen; Elizabeth M Barbeau; Anne M Stoddard; Mary Kay Hunt; Roberta Goldman; Ann Smith; Angela A Brennan; Lorraine Wallace
Journal:  Cancer Causes Control       Date:  2007-02       Impact factor: 2.506

Review 4.  How can we increase translation of research into practice? Types of evidence needed.

Authors:  Russell E Glasgow; Karen M Emmons
Journal:  Annu Rev Public Health       Date:  2007       Impact factor: 21.981

5.  Feasibility of promoting smoking cessation in small worksites: an exploratory study.

Authors:  Lara P Tiede; Deborah J Hennrikus; Barry B Cohen; Diana L Hilgers; RaeJean Madsen; Harry A Lando
Journal:  Nicotine Tob Res       Date:  2007-01       Impact factor: 4.244

6.  Smoking cessation: next steps for special populations research and innovative treatments.

Authors:  Belinda Borrelli
Journal:  J Consult Clin Psychol       Date:  2010-02

7.  Pediatric-based smoking cessation intervention for low-income women: a randomized trial.

Authors:  Susan J Curry; Evette J Ludman; Elinor Graham; James Stout; Louis Grothaus; Paula Lozano
Journal:  Arch Pediatr Adolesc Med       Date:  2003-03

8.  A worksite smoking modification competition: potential for public health impact.

Authors:  R C Klesges; M M Vasey; R E Glasgow
Journal:  Am J Public Health       Date:  1986-02       Impact factor: 9.308

Review 9.  Diagnostic accuracy of Spanish language depression-screening instruments.

Authors:  Daniel S Reuland; Andrea Cherrington; Garth S Watkins; Daniel W Bradford; Roberto A Blanco; Bradley N Gaynes
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

10.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03
View more
  4 in total

1.  Direct Outreach in Bars and Clubs to Enroll Cigarette Smokers in Mobile Cessation Services: Exploratory Study.

Authors:  Patricia Chalela; Alfred L McAlister; Cliff Despres; Edgar Muñoz; Pramod Sukumaran; David Akopian; Sahak Kaghyan; Jesus Trujillo; Amelie G Ramirez
Journal:  JMIR Form Res       Date:  2022-06-02

2.  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Bosun Hong; Jonathan Livingstone-Banks; Hannah Wheat; Thomas R Fanshawe
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

3.  Reach versus effectiveness: The design and protocol of randomized clinical trial testing a smartphone application versus in-person mindfulness-based smoking cessation intervention among young cancer survivors.

Authors:  Taghrid Asfar; Tulay Koru-Sengul; Debra Annane; Laura A McClure; Amanda Perez; Michael A Antoni; Judson Brewer; David J Lee
Journal:  Contemp Clin Trials Commun       Date:  2021-05-19

4.  Comparing Methods of Recruiting Spanish-Preferring Smokers in the United States: Findings from a Randomized Controlled Trial.

Authors:  Patricia Medina-Ramirez; Patricia Calixte-Civil; Lauren R Meltzer; Karen O Brandon; Ursula Martinez; Steven K Sutton; Cathy D Meade; Margaret M Byrne; Thomas H Brandon; Vani N Simmons
Journal:  J Med Internet Res       Date:  2020-08-14       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.